BCCIP (NM_078468) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC203061 |
| Predicted MW | 36.1 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_510868 |
| RefSeq Size | 1261 |
| RefSeq ORF | 942 |
| Synonyms | TOK-1; TOK1 |
| Locus ID | 56647 |
| UniProt ID | Q9P287 |
| Cytogenetics | 10q26.2 |
| Summary | This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene. provided by RefSeq, Jul 2008 |
| Protein Families | Druggable Genome, Stem cell - Pluripotency |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "BCCIP" proteins (7)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| LC409214 | Lyophilized BCCIP HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC409215 | Lyophilized BCCIP HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC413842 | Lyophilized BCCIP HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY409214 | Transient overexpression lysate of BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant B (as WB positive control) | 100 ug |
$436.00
|
|
| LY409215 | Transient overexpression lysate of BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant C (as WB positive control) | 100 ug |
$436.00
|
|
| LY413842 | Transient overexpression lysate of BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant A (as WB positive control) | 100 ug |
$436.00
|
|
| TP303061 | Recombinant protein of human BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant B, 20 µg | 20 ug |
$737.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.